Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A study from researchers at Wake Forest University School of Medicine highlights a new approach in addressing conductive hearing loss. A team of scientists, led by Mohammad J. Moghimi, Ph.D., ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...